New drug trial aims to help blood cancer patients recover faster after transplant
NCT ID NCT07450313
Summary
This study is testing whether a drug called luspatercept can help patients with blood cancers recover from anemia (low red blood cells) after a stem cell transplant. Researchers want to see if the drug reduces the need for blood transfusions and helps the new stem cells work better. The study will enroll 20 adults in China who have recently had a transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HSCT are added.
By submitting, you agree to our Terms of use
Conditions
Explore the condition pages connected to this study.